Pfizer and BioNTech have entered into an agreement with the European Commission (EC) to supply an additional 200 million doses of their Covid-19 vaccine. The deal also includes
The post Pfizer, BioNTech to supply 200 million more Covid-19 vaccine doses to Europe appeared first on Pharmaceutical Business review.
This is not a CAPTIS article. Originally, it was published here.